Health system intelligence profile
HCA Healthcare
Last reviewed August 30, 2026
Intelligence summary
Documented successes: Has conducted more than 850 first-in-human clinical trials since inception (scri.com, 2025); Research network of more than 1,300 physicians at over 200 research locations across more than 20 states (scri.com, 2025); Presented over 155 accepted abstracts at the 2025 ASCO Annual Meeting, including findings from 55 early-phase trials; RESTRUCTURED, NOT WOUND DOWN: SCRI was combined with McKesson's US Oncology Research in a joint venture announced in 2022 in which McKesson owns 51% and holds operating control, with SCRI's Dee Anna Smith as CEO and Skip Burris as President; McKesson separately acquired Genospace, SCRI's personalized medicine platform, as part of the transaction
Mandate and remit
Sarah Cannon Research Institute is the oncology research and drug-development organization founded within HCA Healthcare that runs community-based cancer clinical trials. It operates a large network of affiliated physicians and research sites that gives community oncology patients access to early-phase and pivotal trials close to home. SCRI runs first-in-human and early-phase studies for pharmaceutical and biotechnology sponsors, functioning as the bridge between industry drug developers and community cancer programs. Since 2022 it has operated as part of a joint venture that combined SCRI with McKesson's US Oncology Research, with McKesson holding majority ownership and operating control. It engages outside companies as a contract and collaborative research partner for sponsors seeking trial sites, data and investigator expertise.
These routes appear in the program's sourced public record.
Documented successes
Has conducted more than 850 first-in-human clinical trials since inception (scri.com, 2025); Research network of more than 1,300 physicians at over 200 research locations across more than 20 states (scri.com, 2025); Presented over 155 accepted abstracts at the 2025 ASCO Annual Meeting, including findings from 55 early-phase trials; RESTRUCTURED, NOT WOUND DOWN: SCRI was combined with McKesson's US Oncology Research in a joint venture announced in 2022 in which McKesson owns 51% and holds operating control, with SCRI's Dee Anna Smith as CEO and Skip Burris as President; McKesson separately acquired Genospace, SCRI's personalized medicine platform, as part of the transaction
Organizational home: Sarah Cannon Research Institute, HCA Healthcare
Use the program's published contact route for partnership, licensing, innovation, or program inquiries.
Comparable records based on shared public taxonomy, location, or commercialization route.
Same state · Same program type · Same commercialization route
Nashville, Tennessee
Care Transformation and Innovation (CT&I)
Care Transformation and Innovation is HCA Healthcare's internal department for redesigning care delivery and moving technology into clinical workflows across the company's hospitals.
Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same program type · Same commercialization route
Celebration, Florida
AdventHealth Nicholson Center
The AdventHealth Nicholson Center is a 54,000-square-foot medical learning and simulation incubation center in Celebration, Florida, which AdventHealth describes as one of the nation's largest and most experienced facilities of its kind.
Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same program type · Same commercialization route
Charlotte, North Carolina
Advocate Health Innovation (Innovative Collaborations and Technology Transfer Office)
Advocate Health's enterprise innovation function is led by a Chief Innovation and Commercialization Officer and combines an external-partnership front door with an internal commercialization office.
Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same program type · Same commercialization route
Charlotte, North Carolina
The Pearl
The Pearl is Advocate Health and Atrium Health's innovation district in Charlotte's historic Brooklyn neighborhood, launched June 2, 2025 in partnership with Wexford Science & Technology and Ventas.
Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same program type · Same commercialization route
Winston-Salem, North Carolina
Center for Healthcare Innovation (CHI)
The Center for Healthcare Innovation is the implementation-focused innovation engine inside Atrium Health Wake Forest Baptist, built around the premise that it takes an average of 17 years to move medical discoveries into mainstream care and that the gap can be narrowed.
Academic · Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same program type · Same commercialization route
Chicago, Illinois
Innovate2Impact (I2I) Program
Innovate2Impact is the innovation and intellectual property program of Lurie Children's and the Stanley Manne Children's Research Institute, created to bridge the gap between discovery and usable products and technologies.
Children's · Nonprofit
Read the intelligence briefReviewed August 30, 2026
Reviewed August 30, 2026. External source links open in a new tab.
Confidential comparison
Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio. The public directory does not score or rank programs.